Medical School of Nanjing University, Nanjing, Jiangsu, 210093, China.
National Clinical Research Center for Kidney Disease, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, 210002, China.
Nat Commun. 2022 Jan 10;13(1):31. doi: 10.1038/s41467-021-27660-3.
Papillary renal cell carcinoma (pRCC) is the most heterogenous renal cell carcinoma. Patient survival varies and no effective therapies for advanced pRCC exist. Histological and molecular characterization studies have highlighted the heterogeneity of pRCC tumours. Recent studies identified the proximal tubule (PT) cell as a cell-of-origin for pRCC. However, it remains elusive whether other pRCC subtypes have different cell-of-origin. Here, by obtaining genome-wide chromatin accessibility profiles of normal human kidney cells using single-cell transposase-accessible chromatin-sequencing and comparing the profiles with pRCC samples, we discover that besides PT cells, pRCC can also originate from kidney collecting duct principal cells. We show pRCCs with different cell-of-origin exhibit different molecular characteristics and clinical behaviors. Further, metabolic reprogramming appears to mediate the progression of pRCC to the advanced state. Here, our results suggest that determining cell-of-origin and monitoring origin-dependent metabolism could potentially be useful for early diagnosis and treatment of pRCC.
乳头状肾细胞癌 (pRCC) 是最具异质性的肾细胞癌。患者的生存情况各不相同,晚期 pRCC 也没有有效的治疗方法。组织学和分子特征研究强调了 pRCC 肿瘤的异质性。最近的研究确定近端肾小管 (PT) 细胞为 pRCC 的起源细胞。然而,其他 pRCC 亚型是否具有不同的起源细胞仍不清楚。在这里,我们通过使用单细胞转座酶可及染色质测序获得正常人肾脏细胞的全基因组染色质可及性图谱,并将图谱与 pRCC 样本进行比较,发现除了 PT 细胞外,pRCC 还可以来源于肾集合管主细胞。我们表明,具有不同起源细胞的 pRCC 表现出不同的分子特征和临床行为。此外,代谢重编程似乎介导了 pRCC 向晚期的进展。在这里,我们的结果表明,确定起源细胞并监测起源依赖性代谢可能对 pRCC 的早期诊断和治疗有用。